首页|基于FAERS数据库分析波生坦药物不良事件

基于FAERS数据库分析波生坦药物不良事件

扫码查看
目的:基于美国食品药品监督管理局不良事件报告系统(FAERS),挖掘波生坦不良事件信号,判断其安全性,以期临床安全用药提供参考.方法:选取FAERS数据库2016年1季度~2022年2季度数据信息,比照MedDRA不良事件编码处理数据,提取以波生坦为首要怀疑药品的不良事件报告,采取比例报告比值法(PRR)和报告比值法(ROR)对信号进行分析.结果:以波生坦为首要怀疑药品的不良事件报告中,女性占比(61.51%)高于男性(21.40%);通过对器官系统分类(SOC)分析发现波生坦产生不良反应主要集中在全身性疾病及给药部位各种反应、呼吸系统、胸及纵隔疾病、感染及侵染类疾病;对首选语(PT)分析发现呼吸困难、死亡、感染性肺炎的发生排在前3位;对低位语(LLT)分析发现波生坦易导致死亡、基因突变、肺水肿等不良事件的发生.结论:通过对FAERS数据库中波生坦不良反应的挖掘,从SOC、PT、LLT 3个层次分析了不良事件特点,为波生坦在临床中的安全使用提供了参考依据.
Analysis of Adverse Drug Events with Bosentan Based on FAERS Database
Objective:To mine adverse event signals of bosentan based on the US Food and Drug Administration Adverse Event Reporting System(FAERS)and assess the drug's safety,so as to provide reference for the safe application of the drug in medical institutions.Methods:The data from the first quarter of 2016 to the second quarter of 2022 were searched from the FAERS database,and subsequently processed according to MedDRA for coding adverse events.The adverse event reports with bosentan as the primary suspect drug were extracted.The proportional reporting ratio(PRR)and report odds ratio(ROR)were used to detect signals.Results:The analysis of adverse event reports with bosentan as the primary suspect drug showed that the proportion of events reported in females(61.51%)was higher than that in males(21.40%).The analysis according to organ system class(SOC)revealed that adverse reactions with bosentan were mainly concentrated in general disorders and administration site conditions,respiratory,thoracic and mediastinal diseases,and infections and infestations;The analysis according to preferred terms(PT)showed that the top three events were dyspnoea,death,and pneumonia.The analysis according to low level term(LLT)found that bosentan frequently led to such adverse events as death,gene mutation,pulmonary edema,etc.Conclusion:Through mining the adverse reactions with bosentan using the FAERS database,the characteristics of adverse events were analyzed from SOC,PT and LLT levels,providing a reference for the safe use of bosentan in clinical practice.

bosentanFAERS databaseadverse drug reactions and eventssignal miningUS Food and Drug Administration

袁秀芝、唐静

展开 >

华中科技大学同济医学院附属梨园医院药剂科,武汉 430077

波生坦 FAERS数据库 药物不良事件 信号挖掘 美国食品药品监督管理局

2024

中国合理用药探索
中国执业药师协会

中国合理用药探索

影响因子:0.62
ISSN:2096-3327
年,卷(期):2024.21(5)